Title: DOE, mclean hospital, benzodiazepine testing
Ended Awarded Last action
- Contract number
- 15DDHQ24F00000794
- Awardee
-
The Mclean Hospital Corporation UEI MCKWJYCWNVN3
- Awarding agency
-
Drug Enforcement Administration
Department of Justice
- Obligated
- $99,388
Award facts
- Contract value 87% obligated
- $114,422.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Belmont, MA 02478, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$15,034 | |
| Original award | $114,422 |
About this award
The Drug Enforcement Administration (DEA) awarded a task order valued at $114,422.04 to The McLean Hospital Corporation for benzodiazepine testing services under a blanket purchase agreement established May 1, 2024. This firm fixed-price call, issued under BPA reference 15DDHQ23Q00000149, covers performance from July 18, 2024, through July 17, 2025, with ultimate completion by August 15, 2025. The work will be performed at McLean Hospital's facilities in Belmont, Massachusetts. This is a child contract under the DEA's five-year, $1.06 million single-award BPA with McLean Hospital, which serves as an indefinite delivery, indefinite quantity vehicle for specialized scientific expertise in monitoring and regulating controlled substances and emerging drugs. The contract was awarded without set-aside designation under full and open competition.
McLean Hospital, a Harvard Medical School-affiliated non-profit psychiatric teaching hospital, provides the DEA with specialized scientific research services and clinical expertise in substance abuse monitoring and pharmaceutical regulation. The institution has demonstrated substantial federal contracting capacity across multiple agencies, including significant ongoing contracts with the National Institute on Drug Abuse and multiple active research grants from National Institutes of Health institutes. Under this benzodiazepine testing task order, McLean Hospital will leverage its established capabilities in substance abuse pharmacology and psychiatric research to support the DEA's drug regulatory functions and controlled substance characterization efforts.
Quick answers
Who was awarded contract 15DDHQ24F00000794?
15DDHQ24F00000794 was awarded to The Mclean Hospital Corporation by Drug Enforcement Administration (Department of Justice) on August 16, 2024.
How much is contract 15DDHQ24F00000794 worth?
The government has obligated $99,388 on 15DDHQ24F00000794. Its current value, with exercised options, is $114,422.
Is contract 15DDHQ24F00000794 an order under another contract?
Yes. 15DDHQ24F00000794 is a BPA call under 15DDHQ24A00000008, a blanket purchase agreement.
Was contract 15DDHQ24F00000794 competed?
The extent of competition for 15DDHQ24F00000794 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award